Tumor suppressor death-associated protein kinase 1 inhibits necroptosis by p38 MAPK activation

Area of Science:

• Cellular biology
• Molecular mechanisms of cell death

Background:

• Death-associated protein kinase 1 (DAPK1) is a known regulator of apoptosis and autophagy.
• The precise role of DAPK1 in other forms of programmed cell death, such as necroptosis, remains largely unexplored.

Purpose of the Study:

• To investigate the function of DAPK1 in the regulation of necroptosis.
• To elucidate the molecular mechanisms by which DAPK1 influences necroptosis signaling.

Main Methods:

• Utilized DAPK1-deficient cell models (macrophages, dendritic cells, HT-29 cells) via knockdown and knockout.
• Assessed necroptosis sensitivity and formation of the RIPK1-RIPK3-MLKL complex.
• Analyzed MAPK signaling pathways, including p38 MAPK and MK2 activation, and RIPK1 phosphorylation at S321.

Main Results:

• DAPK1 deficiency significantly increased susceptibility to necroptosis in various cell types.
• Necroptosis induction in DAPK1-deficient cells correlated with enhanced RIPK1-RIPK3-MLKL necrosome formation.
• DAPK1 selectively promotes p38 MAPK-MK2 activation, leading to RIPK1 S321 phosphorylation and suppression of necroptosis.

Conclusions:

• DAPK1 plays a novel inhibitory role in necroptosis.
• DAPK1's function in necroptosis regulation is mediated through selective activation of the p38 MAPK-MK2 pathway.
• Targeting DAPK1 offers a potential strategy for modulating necroptosis and associated inflammatory responses.